Central versus local adjudication of myocardial infarction in a cardiac biomarker trial

American Heart Journal

Volumn 165, Issue 3, 2013, Pages

  Smith, Stephen W ^a,m   Diercks, Deborah B ^b   Nagurney, John T ^c   Hollander, Judd E ^d   Miller, Chadwick D ^e   Schrock, Jon W ^f   Singer, Adam J ^g   Apple, Fred S ^h   McCullough, Peter A ⁱ   Ruff, Christian T ^j   Sesma Jr , Arturo ^k   Peacock, W Frank ^l  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f METROHEALTH MEDICAL CENTER   (United States)

^g STONY BROOK UNIVERSITY   (United States)

^h UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

ⁱ St John Providence Health System   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k ST CATHERINE UNIVERSITY   (United States)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

^m Hennepin Emergency Department   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR PROCEDURE; CENTRAL VERSUS LOCAL ADJUDICATION; CLINICAL PROTOCOL; DISEASE MARKER; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 84875212538     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.12.012     Document Type: Article

References (17)

1. E.M. Antman, J.P. Bassand, and W. Klein Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 36 3 2000 959 969
2. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653
3. C.B. Granger, V. Vogel, and S.R. Cummings Do we need to adjudicate major clinical events? Clinical trials (London, England) 5 1 2008 56 60
4. F.S. Apple, D. Morrow, and C. Zaugg The challenges and concerns companies face pertaining to the US Food and Drug Administration 510(k) process for cardiac biomarkers Clin Chem 58 1 2012 31 38
5. Food and Drug Administration. Points to consider for Troponin pre-IDE and 510(k) submissions. Unpublished, Circulated among Industry 2010; April 30.
6. W.F. Peacock, J. Nagurney, and R. Birkhahn Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum Am Heart J 162 5 2011 893 899
7. J.E. Hollander, A.L. Blomkalns, and G.X. Brogan Standardized reporting guidelines for studies evaluating risk stratification of ED patients with potential acute coronary syndromes Acad Emerg Med 11 12 2004 1331 1340
8. J.T. Nagurney, D.F. Brown, and C. Chae Disagreement between formal and medical record criteria for the diagnosis of acute coronary syndrome Acad Emerg Med 12 5 2005 446 452
9. D.B. Diercks, W.F. Peacock, and J.E. Hollander Diagnostic accuracy of a point-of-care troponin I assay for acute myocardial infarction within 3 hours after presentation in early presenters to the emergency department with chest pain Am Heart J 163 1 2012 74 80 e4
10. K.W. Mahaffey, R.A. Harrington, and M. Akkerhuis Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study Current controlled trials in cardiovascular medicine 2 4 2001 187 194
11. K.W. Mahaffey, R.A. Harrington, and M. Akkerhuis Systematic adjudication of myocardial infarction end-points in an international clinical trial Current controlled trials in cardiovascular medicine 2 4 2001 180 186
12. E. Giannitsis, M. Becker, and K. Kurz High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission Clinical chemistry 56 4 2010 642 650
13. F.S. Apple, L.A. Pearce, and S.W. Smith Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events Clinical chemistry 55 5 2009 930 937
14. T. Reichlin, A. Irfan, and R. Twerenbold Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction Circulation 124 2 2011 136 145
15. M.S. Sabatine, D.A. Morrow, and J.A. de Lemos Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 Eur Heart J 30 2 2009 162 169
16. P.A. Kavsak, D.T. Ko, and X. Wang 2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay Clinical chemistry 56 3 2007 487 489
17. A.H. Wu, Q.A. Lu, and J. Todd Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice Clinical chemistry 55 1 2009 52 58